BayWa Shares Rally as Agrana Profits and Solar Sale Offset Legal Cloud

BayWa shares close up 2.38% at €10.75, buoyed by Agrana's fivefold profit jump and German power plant law, but remain down 55% from highs as a probe into former executives weighs.

BayWa’s stock delivered a rare bright spot on Friday, closing up 2.38% at €10.75 after touching an intraday high of €10.90 — a gain of 3.81% at the peak. The move shaved the year-to-date decline to 35.82% (or 34.93% from the session high), but the shares still trade more than 55% below the December 2025 high of €23.90. The rally unfolded against a deeply complex backdrop: a probe into former executives and an extended rescue blueprint compete for investor attention with genuinely positive operational updates from two of the group’s key businesses.

The most significant catalyst came from Vienna. Agrana, the Austrian starch and sugar group in which BayWa holds a major stake, reported first-quarter results for its 2026/27 financial year on July 10. Revenue dipped 2.8% to €855.3 million, but operating profit surged more than fivefold to €35.4 million, driven by the starch and sugar divisions. Net income swung from a loss to a profit of €19.3 million. Agrana’s management signaled a substantially higher full-year EBIT, offering some relief for BayWa’s own beleaguered balance sheet by bolstering the carrying value of a key equity investment.

Domestic regulatory news also provided tailwinds. On July 9, the German Bundestag passed a new power plant law that mandates the auction of 11 gigawatts of new gas-fired capacity, to be grid-connected by 2031 and converted to hydrogen-readiness by 2045. BayWa, active in renewable energy and energy infrastructure via its subsidiaries, stands to benefit from the planning certainty the law creates for hybrid projects. A new surcharge from 2031 will finance the build-out, accelerating the availability of dispatchable capacity to complement renewables.

Yet for all the positive noise from operations and policy, the legal front remains troubling. The Munich public prosecutor’s office has opened investigations into former members of BayWa’s management board on suspicion of balance-sheet manipulation and potential breach of trust linked to past expansion. Details are scarce, but analysts view the probe as an additional drag on investor and creditor confidence at a time when the group is already navigating a crisis that began with an acute liquidity squeeze in July 2024.

Alongside the investigations, the group’s renewable energy subsidiary BayWa r.e. demonstrated it can still execute. The company sold a 16.8-megawatt solar project in Castets, southern France, to a consortium of Avergies and Terra Energies. Construction is due to start in September 2026, and the plant is expected to supply electricity to approximately 3,800 households. For the parent, the deal signals that the core renewables business retains operational viability and can generate cash through asset sales — a crucial liquidity channel as restructuring efforts enter a decisive phase.

The restructuring framework itself was formalized in a preliminary agreement reached with creditors in June. The timeline now runs until the end of 2030, and the key pillars are clear. Up to €700 million of financial liabilities will be converted into subordinated instruments to strengthen equity. A capital increase of at least €220 million is planned for 2029, which will dilute existing shareholders. The group will refocus on agriculture, technology and building materials, divesting the heat and mobility division by the end of 2029. Market participants expect a legally binding agreement by autumn 2026 — until then, the stock remains a bet on the outcome of those negotiations.

Chart technicians see little relief in the price action. The shares ended the week 6.93% lower and stand 27.97% below the 200-day moving average of €14.93. The 50-day average of €12.22, about 12% above Friday’s close, marks the next resistance. The 52-week low of €9.72, set on June 19, provides support just 12% below current levels. The relative strength index closed at 42.5 (after peaking at 44.1 intraday), indicating neutral territory. Annualized 30-day volatility of 52.24% — just above 53% by some measures — underlines that outsized moves in either direction remain the norm.

Friday’s rally may have offered a reprieve, but it does not erase the fundamental tension. Operational progress at Agrana and BayWa r.e. provides a narrative of underlying value, while the criminal probe and the long, dilutive restructuring path keep the stock firmly in distressed territory. The coming weeks will test whether the €12.22 level can be breached to the upside — and whether the confidence-building effect of the scheduled restructuring agreement can outweigh the legal and financial overhang.